Skip to Content
End of Year Sale. Save up to twenty-five percent off sitewide.End of Year Sale. Save up to twenty-five percent off sitewide.

Hematopoietic Cell Transplantation for Malignant Conditions, 1st Edition

Authors :
Qaiser Bashir & Mehdi Hamadani
Date of Publication: 02/2019
Get a quick, expert overview of hematologic and non-hematologic malignancies for which hematopoietic cell transplantation is a treatment option. Drs. Qaiser Bashir and Mehdi Hamadani provide easy-to-find information on basic science of hematopoietic ...view more

Get a quick, expert overview of hematologic and non-hematologic malignancies for which hematopoietic cell transplantation is a treatment option. Drs. Qaiser Bashir and Mehdi Hamadani provide easy-to-find information on basic science of hematopoietic cell transplantation, pharmacology, workflows and procedures, possible complications and side effects, in addition to the role of HCT in conjunction with clinical cellular therapy.

Add to Cart

Get a quick, expert overview of hematologic and non-hematologic malignancies for which hematopoietic cell transplantation is a treatment option. Drs. Qaiser Bashir and Mehdi Hamadani provide easy-to-find information on basic science of hematopoietic cell transplantation, pharmacology, workflows and procedures, possible complications and side effects, in addition to the role of HCT in conjunction with clinical cellular therapy.


Key Features
  • Discusses high-dose chemotherapeutic regimens and radiation therapy, patient and donor selection and workup, as well as other key aspects of hematopoietic cell transplantation.
  • Includes practical information on complications, infectious disease, and special populations such as patients with HIV infection.
  • Consolidates today’s available information in this fast-changing area into one convenient resource.

Author Information
Edited by Qaiser Bashir, MD, Associate Professor of Medicine, Department of Stem Cell Transplantation & Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas and Mehdi Hamadani, Associate Professor of Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin